Clinical Trial Update: Norwalk Vaccine Study [Phase 1, Phase 2]

View source ↗

Summary

Takeda's Norovirus vaccine study, a Phase 1/2 trial for acute gastroenteritis and Norovirus infection, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis
• Norovirus Infection

Drugs mentioned

• Takeda Norovirus vaccine (Norovirus vaccine)

Snippet

Sponsor: Takeda | Conditions: Acute Gastroenteritis, Norwalk Virus Infection | Phase 1, Phase 2 | Status: COMPLETED